Help Memo Therapeutics AG to identify therapeutic monoclonal antibodies against SARS-CoV-2. If you were a Coronavirus patient and have overcome a heavy infection contact them. If you know such patients, please tell them to help in Memo Therapeutics "Hack Corona Initiative".
During the course of infection with COVID-19, patients develop antibodies against the virus. Most of them are non-functional but some very rare show exceptional functionality: These antibodies can be utilized to find therapies as well as vaccines.
Memo Therapeutics AG, an ETH-Spin off in Schlieren, has a proprietary technology to find analyze and develop therapeutic candidates from these ultra rare and optimal antibodies from patients. They would like to utilize their technology and help finding a cure against this viral threat.
Who can participate?
What does Memo Therapeutics require?
To participate, please contact Memo Therapeutics by email